Analysis of delays in the stages of breast cancer care at the University Clinics of Kinshasa
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260871Keywords:
Breast cancer, Delay, UCKAbstract
Background: The DRC faces the paradox of high mortality and low incidence of breast cancer due to late consultations and delayed treatment; however, it lacks studies detailing the different delays of breast cancer management. We initiated this study to assess these delays and identify the associated factors.
Methods: This was a cross-sectional study conducted on 201 records of women followed for breast cancer at the University Clinics of Kinshasa (UCK) from January 2020 to December 2024. Population characteristics and delays were described using descriptive statistics, logistic regression was used to identify factors associated with delays.
Results: The mean age was 48±12 years. 90.8% of patients were diagnosed at advanced stages, 67% received chemotherapy as first treatment. The median patient delay was 365 days, the median diagnostic delay was 26 days, the median treatment delay was 39 days, the median health system delay was 67 days, the median total delay was 398 days. Single women had a higher risk of consultation delay (aOR=2.48; p=0.02), diagnostic delay (aOR=1.79 p=0.01) and treatment delay (aOR=3.67; p=0.04). Women who followed alternative pathways had a higher risk of delay in consultation (aOR=9; p=0.01), diagnosis (aOR=3.27; p=0.02), and treatment (aOR=3.27; p=0.01). Consulting for symptoms other than breast lump was associated with a higher risk of treatment delay (aOR=3.44; p=0.02).
Conclusions: Efforts must be made to address the causes of delayed consultations and to improve the patient care pathway.
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2024;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834
Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nature Medi. 2025;31(4):1154-62. DOI: https://doi.org/10.1038/s41591-025-03502-3
Freihat O, Sipos D, Kovacs A. Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data. Fronti Publ Health. 2025;13:1622954. DOI: https://doi.org/10.3389/fpubh.2025.1622954
Gbenonsi G, Boucham M, Belrhiti Z, Nejjari C, Huybrechts I, Khalis M. Health system factors that influence diagnostic and treatment intervals in women with breast cancer in sub-Saharan Africa: a systematic review. BMC Publ Health. 2021;21(1):1325. DOI: https://doi.org/10.1186/s12889-021-11296-5
Kingu M, Rahma T, Nlandu M, Bebele K, Kiyabwe S, Ukundji O. Epidemiological, clinical and molecular profile of breast cancer in hospitals in the city of Kinshasa, DR Congo. Kisangani Medi. 2019;9(1):326-32.
Espina C, McKenzie F, dos-Santos-Silva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Ann Epidemiol. 2017;27(10):659-71. DOI: https://doi.org/10.1016/j.annepidem.2017.09.007
McGuire A, Brown JA, Malone C, McLaughlin R, Kerin MJ. Effects of age on the detection and management of breast cancer. Cancers. 2015;7(2):908-29. DOI: https://doi.org/10.3390/cancers7020815
Ermiah E, Abdalla F, Buhmeida A, Larbesh E, Pyrhönen S, Collan Y. Diagnosis delay in Libyan female breast cancer. BMC Res Notes. 2012;5(1):452. DOI: https://doi.org/10.1186/1756-0500-5-452
Mousa SM, Seifeldin IA, Hablas A, Elbana ES, Soliman AS. Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation. The Breast. 2011;20(6):555-61.
Otieno ES, Micheni JN, Kimende SK, Mutai KK. Delayed presentation of breast cancer patients. East African Med J. 2010;87(4):147-50. DOI: https://doi.org/10.4314/eamj.v87i4.62410
Agodirin OS, Aremu I, Rahman GA, Olatoke SA, Akande HJ, Oguntola AS, et al. Prevalence of themes linked to delayed presentation of breast cancer in Africa: a meta-analysis of patient-reported studies. JCO Glob Oncol. 2020;6:731-42. DOI: https://doi.org/10.1200/JGO.19.00402
Petrova D, Garrido D, Špacírová Z, Fernández‐Martínez NF, Ivanova G, Rodríguez‐Barranco M, et al. Duration of the patient interval in breast cancer and factors associated with longer delays in low‐and middle‐income countries: A systematic review with meta‐analysis. Psycho‐Oncol. 2023;32(1):13-24. DOI: https://doi.org/10.1002/pon.6064
Donkor A, Lathlean J, Wiafe S, Vanderpuye V, Fenlon D, Yarney J, et al. Factors contributing to late presentation of breast cancer in Africa: a systematic literature review. Arch Medi. 2015;8(2.2):1-0.
Akuoko CP, Armah E, Sarpong T, Quansah DY, Amankwaa I, Boateng D. Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PloS one. 2017;12(2):e0171024. DOI: https://doi.org/10.1371/journal.pone.0171024
Togawa K, Anderson BO, Foerster M, Galukande M, Zietsman A, Pontac J, et al. Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: the African breast cancer-disparities in outcomes cohort study. Int J Cancer 2020;148(9):2212-26. DOI: https://doi.org/10.1002/ijc.33400
Benbakhta B, Tazi M, Benjaafar N, Khattabi A, Maaroufi A. Determinants of patient and health system delays for women with breast cancer in Morocco, 2013. Rev Epidemiol Sante Publique. 2015;63:191e201 DOI: https://doi.org/10.1016/j.respe.2015.03.121
Limam M, Ajmi T, Zedini C, Khelifi A, Mellouli M, El Ghardallou M, et al. Study of breast cancer treatment delays in Sousse, Tunisia. Santé Publique. 2016;28(3):331-40. DOI: https://doi.org/10.3917/spub.163.0331
Mousa SM, Seifeldin IA, Hablas A, Elbana ES, Soliman AS. Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation. The Breast. 2011;20(6):555-61. DOI: https://doi.org/10.1016/j.breast.2011.07.001
Stapleton JM, Mullan PB, Dey S, Hablas A, Gaafar R, Seifeldin IA, et al. Patient‐mediated factors predicting early‐and late‐stage presentation of breast cancer in Egypt. Psycho‐Oncol. 2011;20(5):532-7. DOI: https://doi.org/10.1002/pon.1767
Odongo J, Makumbi T, Kalungi S, Galukande M. Patient delay factors in women presenting with breast cancer in a low income country. BMC Rese Notes. 2015;8(1):467. DOI: https://doi.org/10.1186/s13104-015-1438-8
Unger-Saldaña K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465. DOI: https://doi.org/10.5306/wjco.v5.i3.465
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119e25. DOI: https://doi.org/10.1016/S0140-6736(99)02143-1
Devi BCR, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol. 2007;18(7):1172-6. DOI: https://doi.org/10.1093/annonc/mdm105
Frie KG, Kamate B, Traore CB, Ly M, Malle B, Coulibaly B, et al. Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali. PLoS One. 2018;13(11):e0207928. DOI: https://doi.org/10.1371/journal.pone.0207928
Moodley J, Cairncross L, Naiker T, Constant D. From symptom discovery to treatment-women's pathways to breast cancer care: a cross-sectional study. BMC Cancer. 2018;18(1):312. DOI: https://doi.org/10.1186/s12885-018-4219-7
Pourcel G, Ledesert B, Bousquet PJ, Ferrari C, Viguier J, Buzyn A. Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012. Bulletin du Cancer, 2023;100(12):1237-50. DOI: https://doi.org/10.1684/bdc.2013.1832
Subedi R, Houssami N, Nickson C, Nepal A, Campbell D, David M, et al. Factors influencing the time to diagnosis and treatment of breast cancer among women in low-and middle-income countries: A systematic review. The Breast. 2024;75:103714. DOI: https://doi.org/10.1016/j.breast.2024.103714
Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann oncol. 2012;23(10):2731-7. DOI: https://doi.org/10.1093/annonc/mds101
United Kingdom: NHS National Cancer Action Team. Cancer Reform Strategy, 2007. Available at: www.dh.gov.uk. Accessed 25 August 2015.
Cancer Care Ontario. Target wait times for cancer surgery in Ontario. Final report – revised April 2006. Avalible at: http://www.cancercare.on.ca"www. cancercare.on.ca. Accessed 25 August 2015.
Fekry MA, Yang JC. The social determinants associated with decreased rate of breast cancer screening, delayed presentation, and advanced stage diagnosis of breast cancer: A systematic review. medRxiv. 2023:2023-09. DOI: https://doi.org/10.1101/2023.09.22.23295953
Norsa'adah B, Rampal KG, Mohd Amin R. Time taken for symptom recognition, first consultation, diagnosis and first definitive treatment and its associated factors among women with breast cancer. Asian Pac J Cancer Prev. 2021;22(11):3623-31. DOI: https://doi.org/10.31557/APJCP.2021.22.11.3623
Downloads
Published
How to Cite
Issue
Section
